• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » August 2012 – The CenterWatch Monthly : Print
August 2012 – The CenterWatch Monthly : Print

August 2012 – The CenterWatch Monthly : Print

$79.00

Product Details

Investigator-initiated trials see dramatic drop

Over the past five years, biopharmaceutical companies have invested significant resources building processes to track and manage investigator initiated trial (IIT) programs, in response to increased regulatory pressures. Yet the number of Investigational New Drug (IND) applications filed by independent investigators has declined, as grant spending for IIT programs has slowed at many companies.

Sponsors seeking preferred relationships with best sites

Productivity in the clinical trials industry has been trending negatively, as a reflection of more complex protocols and poor enrollment statistics of study sites. In the hope of shortening recruitment timelines and deflating study budgets, sponsors have been engaging larger numbers of sites to each enroll fewer patients in an attempt to more quickly hit their targets.

Eye On: Allergan

Allergan is a $4.8 billion, multi-specialty healthcare company identifying itself as “global in reach, specialized in focus.” It employs about 10,000 worldwide and maintains a presence in more than 100 countries. By collaborating with medical specialists who provide their perspectives on unmet patient needs, Allergan aims to discover, develop and market innovative pharmaceuticals, biologics, medical devices and over-the-counter consumer products “that enable people to live life to its greatest potential.”...

  • The science of site selection
  • The case for life sciences analytics
  • Regulatory Update
  • Month in Review
  • CRO Industry Update
  • Study Lead Opportunities
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing